Ether lipid-containing pharmaceutical compositions and therapeut

Details Ether lipid-containing pharmaceutical compositions and therapeut Ether lipid-containing pharmaceutical compositions and therapeut

1996-10-15

1999-08-03

Ceperley, Mary E.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Liposomes

A61K 9127

Patent

active

059322420

ABSTRACT:
Pharmaceutical compositions are provided herein that contain, in addition to a pharmaceutically acceptable carrier, a lamellar lipid. The lipid is composed of an ether lipid and a lipid having a molecular shape that is complementary to the molecular shape of the glycerolipid. These compositions can be used therapeutically, for example, in the treatment of cancers and inflammatory conditions.

REFERENCES:
patent: 3752886 (1973-08-01), Munder et al.
patent: 4426525 (1984-01-01), Hozumi et al.
patent: 4734225 (1988-03-01), Eibl
patent: 4804789 (1989-02-01), Eibl
patent: 4965391 (1990-10-01), Counsell et al.
patent: 4983397 (1991-01-01), Schroit et al.
patent: 5077057 (1991-12-01), Szoka, Jr.
patent: 5169637 (1992-12-01), Lenk et al.
Bazill, et al., "Role of Endocytosis in the Action of Ether Lipids on WEHI-3B, HL60, and FDCP-Mix A4 Cells", Cancer Research, 50, 7505-7512, Dec. 1, 1990.
Berdel, "Ether Lipids and Derivatives as Investigational Anticancer Drugs", Onkologie 1990:13:245-250.
Bhatia, et al., "Stereospecific Synthesis of Antitumor Active Thioether PAF Analogs", Lipids, 26(12), 1424-1430, 1991.
Chen, et al., "Microdetermination of Phosphorus", Anal. Chem.,28 (11), 1756-1758; 1956.
Deamer, et al., "Liposome Preparation: Methods and Mechanisms", in Liposomes, Marcel Dekker, ed. M. Ostro, 1983, 27-51.
Dietzfelbinger, et al., "Removal of Breast Cancer Cells from Bone Marrow by in Vitro Purging with Ether Lipids and Cryoperservation", Cancer Research 53, 3747-3751, Aug. 15, 1993.
Gruner, "Nonlamellar Lipis Phases", in The Structure of Biological Membranes, 1992, CRC Press, ed. P. Yeagle, Buffalo, NY, pp. 222-223.
Kumar, et al., "Phosphlipid Deitribution and Headgroup Motion in Phosphatidylcholine Liposomes of Different Size", Biophys. J., 53, 1988, 121a.
Layton, et al., "The Interaction of Liposomes with Cells: The Relation of Cell Specific Toxicity to Lipid Composition", Eur J Cancer, 16, 1529-1538, 1980.
Madden, et al., "Stabilization of bilayer Structure for Unsaturated Phosphatidylethanolamines by Detergents", BBA, 684 (1982), 149-153.
Nairn, et al., "Solutions, Emulsions, Suspensions and Extractives", in Pharmaceutical Sciences, 1985, Mack Publishing Co., Easton, PA.
Papahadjopoulos, et al. "Phospholipid Model Membranes, I. Structural Characteristics of Hydrated Liquid Crystals", BBA 135 (1967) 624-638.
Powis, et al., "Selective Inhibition of Phosphatidyloinositol Phospholipase C by Cytotoxic Ether Lipid Analogues", Cancer Research 52, 2835-2840, May 15, 1992.
Reed, et al., "Antineoplastic Ether-Linked Phospholipid Inudces Differentiation of Acute Myelogenous Leukemic KG-1 Cells Into Macrophase-Like Cells", Life Sciences,49, 1221-1227, 1991.
Runge, "Destruction of human Solid tumors by Alkyl Lysophospholipids", JNCI, 64(6), Jun. 1980, 1301-1306.
Tritton, et al., "How to Kill Cancer Cells: Membranes and Cell signaling as Targets in Cancer Chemotherapy", Cancer Cells, Apr. 1990, 95-105.
Stedman's Medical Dictionary, pp. 707-708.
Stedman's Medical Dictionary, pp. 123-124.
Workman, "Antitumour Ether Lipids: Endocytosis as a Determinant of Cellular Sensitivity", Cancer Cells, 3(8), 315-317, Aug. 1991.
Workman, et al., "Platelet-activating factor (PAF) antagonist WEB 2086 does not modulate the cytotoxicity of PAF of antitumor alkyl lysophospholipids ET-18-O-Methyl and SRI 62-834 in HL-60 promyelocytic leukaemia cells", Biochemical Pharmacology, 41(2), 319-322, 1991.
Wu, et al., "Modified In Vivo behavior of Liposomes Containing Synthetic Glycolipids", BBA 674 (1981), 19-29.
Zeisig, et al., "Antineoplastic activity in vitro of free an liposomal alklyphosphocholines", Anti-Cancer Drugs, 4, 57-64, 1993.

Affiliated with

Also associated with

Rating

Ether lipid-containing pharmaceutical compositions and therapeut does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ether lipid-containing pharmaceutical compositions and therapeut, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ether lipid-containing pharmaceutical compositions and therapeut will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-847568